胞苷脫氨酶(CDA)多克隆抗體
Polyclonal Antibody to Cytidine Deaminase (CDA)
CDD; Cytidine aminohydrolase
- 編號PAC366Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPC366Hu01-胞苷脫氨酶(CDA)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應用WB; IHC; ICC/IF
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Sample: Human Lung cancer Tissue Primary Ab: 10μg/ml Rabbit Anti-Human CDA Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Lung cancer Tissue;
Primary Ab: 10μg/ml Rabbit Anti-Human CDA Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;<br/>Samples: Human Skin cancer Tissue; <br/>Primary Ab: 10μg/ml Rabbit Anti-Human CDA Antibody<br/>Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Bile duct cancer Tissue;
Primary Ab: 10μg/ml Rabbit Anti-Human CDA Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
AF488 staining on IF;
Sample: U2OS cell
Primary Ab: 20μg/ml Rabbit Anti-Human CDA Antibody
Second Ab: 2μg/ml AF488-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb11)
-
Figure. Western Blot; Sample: Recombinant CDA, Human.
-
Western Blot; Samples: Lane1: Hela cell lysate; Lane2: Porcine Kidney lysate;
Primary Ab: 3μg/ml Rabbit Anti-Human CDA Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對CDA的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CDA。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPC366Hu01 | 胞苷脫氨酶(CDA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC366Hu01 | 胞苷脫氨酶(CDA)多克隆抗體 | WB; IHC; ICC/IF |
| MAC366Hu21 | 胞苷脫氨酶(CDA)單克隆抗體 | WB; IHC; ICC; IP. |
| SEC366Hu | 胞苷脫氨酶(CDA)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC366Hu | 胞苷脫氨酶(CDA)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| CGC366Hu01 | 胞苷脫氨酶(CDA)cDNA | PCR、蛋白表達等 |
參考文獻
| 雜志 | 參考文獻 |
| Biomed Pharmacother | The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells [Pubmed: 33059263] |
留言咨詢
